MelbImmunoNetwork

Rapid activation of IL-2 receptor signaling by CD301b+DC-derived IL-2 dictates the outcome of helper T cell differentiation biorxiv.org/cgi/content/sh… #biorxiv_immuno

Our bid to host the 2025 World Cancer Leader’s Summit with @cancervic, @MonashPCCC and @McCabe_Centre has been successful. I couldn't be more proud to welcome this event to Victoria and showcase our world-class hub of cancer innovation and care. uicc.org/announcements/… @uicc

Boosting exhausted T cells: Dr Daniel Utzschneider has identified how T cells can become exhausted from battling cancer, reducing the effectiveness of immunotherapy. He will use his CSL Centenary Fellowship to study these cells. @TheDohertyInst bit.ly/3tlcYzF

📢 The Antiviral Immunity team @BurnetInstitute is recruiting! Are you interested in applying your immunology skills to improving patients outcomes in the clinic? We're looking for a RA or RO to contribute to our COVID-19 vaccine & other virus studies 👇 burnet.edu.au/the-institute/…

See our latest publication in @NatureComms on prostate cancer CAR T cell efficacy. Preclinical studies provide proof of concept that modifying the #TME enhances T cell trafficking and activation @MonashBDI @PeterMacRes #prostatecancer #CARTcells rdcu.be/dk0Ss